medline.ch Gastroenterologie Leber Neoplasie

	Isolated Hepatic Hemangiomatosis Leading to Fatal Consumptive Coagulopathy in an Elderly Patient: A Case Report. Am J Case Rep , Oszytko JK, Chlebowska GM. PMID: 41615903 [PubMed - indexed for MEDLINE]
	Serum Extracellular Vesicle-Associated GULP1 Is a Key Indicator of Hepatocellular Carcinoma. Oncol Res Kim HS, Son JA, Kang M, Kim SS, Baek GO, Yoon MG, Jang SH, Jung D, Han JE, Cheong JY, Eun JW. PMID: 41613803 [PubMed - indexed for MEDLINE]
	Tailored Internet-Delivered Mindfulness-Based Interventions for Patients With Hepatocellular Carcinoma After Transarterial Chemoembolization: Qualitative Study. J Med Internet Res Liu Z, Li M, Jia Y, Chen L. PMID: 41610421 [PubMed - indexed for MEDLINE]
	Differential survival benefit of curative versus non-curative intent treatment in a real-world cohort with early and intermediate-stage hepatocellular carcinoma. Hepatol Commun Goldberg D, John B, Kaplan D, Delgado C, Gaddipati N, Gaddipati S, Blandon C. PMID: 41610143 [PubMed - indexed for MEDLINE]
	Survival Prediction and Treatment Decisions in Hepatocellular Carcinoma: A Deep Learning-Based Radiomics Approach. Br J Hosp Med (Lond) Wei X, Xiao J, Liu Y, Yang C, Luo Z, Tang M, Chen X. PMID: 41609156 [PubMed - indexed for MEDLINE]
	Improving Survival Models in Health Care by Balancing Imbalanced Cohorts: A Novel Approach. JCO Clin Cancer Inform Ning C, Bertsimas D, Lønning PE, Auecio FN, Burkhart R, Balzer F, Buettner S, Baba H, Endo I, Stasinos G, Gagnière J, Verhoef C, Kreis ME, Margonis GA. PMID: 41604602 [PubMed - indexed for MEDLINE]
	Single-cell transcriptomics reveals a novel mechanism of RDH16 regulating immune infiltration in hepatocellular carcinoma. Front Immunol Zhang Z, Fan R, Ma J, Li D, Jiang Y, Liu F, Gong Q. PMID: 41601632 [PubMed - indexed for MEDLINE]
	Immune cell metabolic reprogramming in hepatocellular carcinoma: mechanisms, tumor microenvironment, and future immunotherapeutic directions. Front Immunol Zhou L, Zhang W, Liu Z, Xie Y, Jiang K. PMID: 41601626 [PubMed - indexed for MEDLINE]
	Disrupted Vitamin D Metabolism in Hepatocellular Carcinoma: Free and Bioavailable 25(OH)D as Novel Biomarkers of Hepatic Reserve and Clinical Risk. Molecules Osredkar J, Rakusa M, Jerin A, , Zaplotnik M, , Siuka D. PMID: 41599322 [PubMed - indexed for MEDLINE]
	Role of Liver Function in the Multiparametric Assessment of Hepatocellular Carcinoma. Medicina (Kaunas) Melandro F, Centonze L, Celsa C, Famularo S, Ghinolfi D, Nardelli S, Pallozzi M, Abenavoli L, Romano F, Ponziani FR, Russo FP, Lai Q. PMID: 41597423 [PubMed - indexed for MEDLINE]
	Establishment of Patient-Derived Organoids from Hepatocellular Carcinoma: Preliminary Data on Yield, Histopathological Concordance, and Methodological Challenges. Cells Lo Re O, Corti C, Cerrito L, Cesari E, Creta E, De Maio F, Di Prima A, Facciuto V, Ferraro C, Huqi E, Liotta R, Lo Pinto M, Pagano D, Perriera R, Petito V, Santarelli G, Santopaolo F, Stella L, Tortomasi F, Sette C, Gruttadauria S, Giuliante F, Zito G, Ponziani FR. PMID: 41597200 [PubMed - indexed for MEDLINE]
	Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trial. Cancer Immunol Immunother Shin H, Park Y, Song BG, Choi WM, Han HJ, Lee Y, Song TJ, Yeon JE, Lim YS, Hur MH, Lee YB, Cho EJ, Yu SJ, Kim YJ, Lee JH, Yoon JH, Lee JH. PMID: 41591582 [PubMed - indexed for MEDLINE]
	Non-thyroidal illness syndrome predicts poor prognosis in hepatocellular carcinoma patients treated with atezolizumab and bevacizumab. Cancer Immunol Immunother Chen IW, Lin CW, Lin PT, Teng W, Su CW, Wu TH, Hsieh YC, Chen WT, Lin CC, Lin SM, Lin CY. PMID: 41591568 [PubMed - indexed for MEDLINE]
	Case 344: Hepatic Epithelioid Hemangioendothelioma. Radiology Daggumati L, Stark L, Booth AL, Fraum TJ. PMID: 41591253 [PubMed - indexed for MEDLINE]
	Frailty in Hepatocellular Carcinoma: An Unsettled Clinical Challenge. Curr Oncol Bonato A, Guerra P, Vitale A, Martini A, Associazione Italiana per lo Studio del Fegato (AISF) HCC Special Interest Group. PMID: 41590378 [PubMed - indexed for MEDLINE]
	Parenchymal-Sparing Strategy in Colorectal Liver Metastases: A Single-Center Experience. Curr Oncol Pozzi E, La Barba G, D'Acapito F, Turrini R, Cantelli GE, Marchetti G, Zucchini V, Ercolani G. PMID: 41590366 [PubMed - indexed for MEDLINE]
	Hepatocellular Carcinoma Around the Clock. Curr Oncol Machado MV. PMID: 41590352 [PubMed - indexed for MEDLINE]
	Impact of Prior Treatment History on Recurrence After Complete Response to Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma. Cancer Med Nakabori T, Kawabata M, Mukai K, Hongyo H, Maeda N, Urabe M, Kai Y, Takada R, Ikezawa K, Wada H, Gotoh K, Ohkawa K. PMID: 41588734 [PubMed - indexed for MEDLINE]
	Hepatocellular Carcinoma - from Immunobiology to Immunotherapy. Z Gastroenterol Rennert C, Schultheiß M, Thimme R, Röhlen N, Bengsch B. PMID: 41587554 [PubMed - indexed for MEDLINE]
	Liver-Directed Therapy for Colorectal Cancer: Where Are We Now? Am Soc Clin Oncol Educ Book Song Y, Jeeva M, Liddell RP, Lafaro K, Azad N, Dawson LA, Park LS. PMID: 41587378 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 75039

Seite 1 von 3752

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung